Subscribe To

Price Alert Latest News Economic Calendar News

CE / Celanese Corp. Has Potential Value

Celanese Corp. is an American legacy company that provides essential basic industry products to manufacturers in nearly all industrialised countries. The company is profitable, low risk, has growth potential, is likely to outperform, and has a robust R&D necessary for the chemical and material sciences business. Read More

Demo Live Account See Partner Details

Content Topics

Celanese

Corp

Potential

Value

Stock

CE

Posted: Jun 3 2022, 09:05

Author Name: Seeking Alpha

CE News

By Zacks Investment Research
November 1, 2023

Celanese (CE) to Report Q3 Earnings: What's in the Offing?

Celanese (CE) is expected to have benefited from its cost actions and contributions of acquisitions amid demand headwinds in certain markets in Q3.

By Seeking Alpha
October 18, 2023

Celanese: Highly Leveraged Specialty Materials Leader

Celanese Corporation is a global leader in the production of acetyl products and engineered materials. The company faces challenges due to a stretched

By Zacks Investment Research
October 16, 2023

Here's Why You Should Retain Celanese (CE) in Your Portfolio

Celanese (CE) gains on productivity actions, investments in high-return organic projects and acquisitions amid demand softness and customer destocking

By Zacks Investment Research
October 12, 2023

Celanese (CE) Shares Up 21% YTD: What's Driving the Stock?

Celanese (CE) benefits from its productivity measures, investments in organic projects and strategic acquisitions.

By Zacks Investment Research
September 29, 2023

Celanese (CE) Closes Food Ingredients JV Formation With Mitsui

Celanese (CE) monetizes the majority of its Food Ingredients business while maintaining the demand benefits of raw material integration with the Acety

By InvestorPlace
September 15, 2023

The 3 Most Undervalued Materials Stocks to Buy in September 2023

My mission, should I choose to accept it, is to find the three most undervalued materials stocks to buy in September. Dr. Ed Yardeni and his capable c

By Zacks Investment Research
September 13, 2023

Celanese (CE) Inks Deal With Population Council for VitalDose

The VitalDose platform by Celanese (CE) Delivery Platform has a long history of application in approved parenteral drug options.

By Zacks Investment Research
August 16, 2023

Celanese (CE) Refinances Debt to Extend Maturity & Reduce Costs

Celanese (CE) is refinancing its debt to extend the maturity of its debt and reduce its borrowing costs by 14 basis points.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.